Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Transplant Type
1.1.2. Indication
1.1.3. Implant Type
1.1.4. End – use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Transplant Type Outlook
2.2.2. Indication Outlook
2.2.3. Implant Type Outlook
2.2.4. End – use Outlook
2.2.5. Regional Outlook
2.3. Competitive Insights
Chapter 3. Artificial Corneal Implants Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rising prevalence of eye diseases
3.4.1.2. Huge patient pool and limited supply of donor tissue
3.4.2. Market restraint analysis
3.4.2.1. Shortage of ophthalmologists
3.4.2.2. Complications post – surgery
3.5. Artificial Corneal Implants Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Artificial Corneal Implants: Transplant Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Hard Keratoprosthesis
4.1.2. Soft Keratoprosthesis
4.2. Artificial Corneal Implants Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Artificial Corneal Implants Market by Transplant Type Outlook
4.5. Market Transplant Type & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Hard Keratoprosthesis
4.5.1.1. Market estimates and forecast 2018 – 2030 (Revenue in USD Million)
4.5.1.2. Boston Kpro
4.5.1.2.1. Market estimates and forecast 2018 – 2030 (Revenue in USD Million)
4.5.1.3. Osteo – Odonto – Keratoprosthesis
4.5.1.3.1. Market estimates and forecast, 2018 – 2030 (Revenue in USD Million)
Chapter 5. Artificial Corneal Implants: Indication Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Stevens – Johnson Syndrome (SJS)
5.1.2. Ocular Cicatricial Pemphigoid (OCP)
5.1.3. Ocular Burns
5.1.4. Keratoconus
5.1.5. Corneal Stromal Dystrophies
5.1.6. Others
5.2. Indication Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global Artificial Corneal Implants Market by Indication Outlook
5.5. Market Indication & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Stevens – Johnson Syndrome (SJS)
5.5.1.1. Market estimates and forecast, 2018 – 2030 (Revenue in USD Million)
5.5.2. Ocular Cicatricial Pemphigoid (OCP)
5.5.2.1. Market estimates and forecast, 2018 – 2030 (Revenue in USD Million)
5.5.3. Ocular Burns
5.5.3.1. Market estimates and forecast, 2018 – 2030 (Revenue in USD Million)
5.5.4. Keratoconus
5.5.4.1. Market estimates and forecast, 2018 – 2030 (Revenue in USD Million)
5.5.5. Corneal Stromal Dystrophies
5.5.5.1. Market estimates and forecast, 2018 – 2030 (Revenue in USD Million)
5.5.6. Others
5.5.6.1. Market estimates and forecast, 2018 – 2030 (Revenue in USD Million)
Chapter 6. Artificial Corneal Implants: Implant Type Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Synthetic
6.1.2. Biosynthetic
6.2. Implant Type Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global Artificial Corneal Implants Market by Indication Outlook
6.5. Market Indication & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Synthetic
6.5.1.1. Market estimates and forecast, 2018 – 2030 (Revenue in USD Million)
6.5.2. Biosynthetic
6.5.2.1. Market estimates and forecast, 2018 – 2030 (Revenue in USD Million)
Chapter 7. Artificial Corneal Implants Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2022
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Product, & Forecasts and Trend Analysis, 2018 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8. Europe
7.8.1. UK
7.8.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.6. Denmark
7.8.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.7. Sweden
7.8.7.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.8. Norway
7.8.8.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.9.2. India
7.9.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.9.3. China
7.9.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.9.4. South Korea
7.9.41 Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.9.5. Thailand
7.9.5.1 Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.9.6. Australia
7.9.6.1 Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.11. MEA
7.11.1. South Africa
7.11.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.11.2. Saudi Arabia
7.11.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.11.4. Kuwait
7.11.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.2.2. Market Leaders
8.2.3. Emerging Players
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2022
8.3.4. FCI Ophthalmics, Inc.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Beijing Microkpro Medical Instrument Co. Ltd.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. DIOPTEX Medizinprodukte Forschungs
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. KeraMed, Inc.
8.3.7.1. Overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. EyeYon
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives